Seven-Gene Signature Has Linked to Preeclampsia Risk
Researchers identified a molecular profile that could one day help clinicians screen for preeclampsia risk.
Updated on Sept. 24, 2026 in Pregnancy
Scientists have identified a specific seven-gene signature in placental tissues that may help stratify patients by their risk of developing preeclampsia. This preliminary finding marks a potential step toward better understanding the molecular drivers of the condition.
Why it matters
Preeclampsia is a complex pregnancy complication, and finding more precise ways to assess risk could eventually improve monitoring and care strategies. This research highlights how specific transcriptomic changes in the placenta contribute to the disease's underlying biology.
In a study using sequencing and validation sets of 30 total subjects, researchers developed a risk model achieving an AUC of 0.893. These preliminary results identified a gene signature, though the model requires larger, diverse clinical trials to determine real-world performance.
The details
Researchers utilized transcriptomic sequencing and algorithms, including LASSO regression, to identify seven genes linked to preeclampsia. The analysis revealed that five of these genes are elevated in high-risk groups, which also show enrichment in hypoxia and extracellular matrix adhesion pathways. Conversely, the expression of ACOXL and FADS2 was notably higher in the low-risk control group.
Timeline
September 24, 2026: Article publication date.
Health Landscape
This study aligns with the broader push by research initiatives to map the placental transcriptome to improve diagnostic capabilities. It advances the molecular diagnostic goals of the Human Placenta Project by identifying specific biomarkers for pregnancy complications.
This is a preliminary research finding, meaning it does not currently change any standard prenatal screening or clinical testing protocols. If you have concerns about your personal risk for preeclampsia, it is always worth discussing your history and monitoring options with your physician.
The takeaway
Identifying genetic markers in the placenta is a promising area of research for understanding the mechanisms behind preeclampsia. For now, rely on established clinical monitoring and keep regular prenatal appointments to track your blood pressure and overall health.
Further reading
Learn more about the latest developments in maternal health and prenatal care in our Pregnancy section.
More information
Read the full results in the published peer-reviewed research article.
Source note: This article includes information reported by Nature.
